38 employees
Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance.
2016
$1.9M
from 6 investors over 6 rounds
Enzyme raised $1.9M on October 10, 2017
Investors: Data Collective, Refactor Capital, Rock Health Capital, Hack VC and Soma Capital
Enzyme raised $120K on August 21, 2017
Investors: Y Combinator